LIPOPOLYSACCHARIDE, TUMOR-NECROSIS-FACTOR, AND INTERLEUKIN-1 INTERACT TO CAUSE HYPOTENSION

被引:0
|
作者
WEINBERG, JR
BOYLE, P
MEAGER, A
GUZ, A
机构
[1] CHARING CROSS & WESTMINSTER MED SCH,DEPT MED,FULHAM PALACE RD,LONDON W6 8RF,ENGLAND
[2] CHARING CROSS & WESTMINSTER MED SCH,DEPT MED MICROBIOL,LONDON W6 8RF,ENGLAND
[3] NATL INST BIOL STAND & CONTROLS,DIV IMMUNOBIOL,S MIMMS,HERTS,ENGLAND
来源
关键词
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Lipopolysaccharide (LPS) causes the syndrome of septic shock by initiating the release of endogenous mediators such as tumor necrosis factor (TNF) and interleukin-1 (IL-1) from macrophages. Hypotension is one of the important clinical features of septic shock; however, TNF is only hypotensive in high doses. Therefore we have investigated the interactions of low, nonhypotensive doses of LPS, IL-1, and TNF in the restrained unanesthetized rabbit. Combinations of nonhypotensive doses of TNF, IL-1, and LPS produced significant (p < 0.05) decreases in blood pressure as compared with doses of each of the substances alone. TNF bioactivity in animals that were made hypotensive with combinations of TNF, IL-1, and LPS was lower than in animals that were made hypotensive with TNF alone. This suggests that TNF release that is stimulated by LPS is not the sole cause of the hypotension that is seen in this model of endotoxic shock. In this model, interactions of LPS, IL-1, and TNF occur and may explain hypotension during some episodes of sepsis.
引用
收藏
页码:205 / 211
页数:7
相关论文
共 50 条
  • [41] ENDOTOXIN, INTERLEUKIN-1, AND TUMOR-NECROSIS-FACTOR CAUSE NEUTROPHIL-DEPENDENT MICROVASCULAR LEAKAGE IN POSTCAPILLARY VENULES
    YI, ES
    ULICH, TR
    AMERICAN JOURNAL OF PATHOLOGY, 1992, 140 (03): : 659 - 663
  • [42] INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR MEDIATE A PARTIAL ACUTE PHASE RESPONSE
    DARLINGTON, GJ
    WILSON, DR
    JOURNAL OF CELL BIOLOGY, 1986, 103 (05): : A182 - A182
  • [43] CIRCULATING LEVELS OF TUMOR-NECROSIS-FACTOR AND INTERLEUKIN-1 IN CYSTIC-FIBROSIS
    BROWN, MA
    MORGAN, WJ
    FINLEY, PR
    SCUDERI, P
    PEDIATRIC PULMONOLOGY, 1991, 10 (02) : 86 - 91
  • [44] ENDOTOXIN TOLERANCE - INDEPENDENT REGULATION OF INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR EXPRESSION
    ZUCKERMAN, SH
    EVANS, GF
    BUTLER, LD
    INFECTION AND IMMUNITY, 1991, 59 (08) : 2774 - 2780
  • [45] TUMOR-NECROSIS-FACTOR (CACHECTIN) IS AN ENDOGENOUS PYROGEN AND INDUCES PRODUCTION OF INTERLEUKIN-1
    DINARELLO, CA
    CANNON, JG
    WOLFF, SM
    BERNHEIM, HA
    BEUTLER, B
    CERAMI, A
    FIGARI, IS
    PALLADINO, MA
    OCONNOR, JV
    JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 163 (06): : 1433 - 1450
  • [46] TUMOR-NECROSIS-FACTOR, INTERLEUKIN-1, AND INTERLEUKIN-6 IN NORMAL HUMAN-PREGNANCY
    OPSJON, SL
    WATHEN, NC
    TINGULSTAD, S
    WIEDSWANG, G
    SUNDAN, A
    WAAGE, A
    AUSTGULEN, R
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1993, 169 (02) : 397 - 404
  • [47] INVITRO DESENSITIZATION TO LIPOPOLYSACCHARIDE SUPPRESSES TUMOR-NECROSIS-FACTOR, INTERLEUKIN-1 AND INTERLEUKIN-6 GENE-EXPRESSION IN A SIMILAR FASHION
    ZIEGLERHEITBROCK, HWL
    BLUMENSTEIN, M
    KAFFERLEIN, E
    KIEPER, D
    PETERSMANN, I
    ENDRES, S
    FLEGEL, WA
    NORTHOFF, H
    RIETHMULLER, G
    HAAS, JG
    IMMUNOLOGY, 1992, 75 (02) : 264 - 268
  • [48] INTERLEUKIN-1, TUMOR-NECROSIS-FACTOR AND LIPOPOLYSACCHARIDE ADDITIVELY STIMULATE PRODUCTION OF ADRENOMEDULLIN IN VASCULAR SMOOTH-MUSCLE CELLS
    SUGO, S
    MINAMINO, N
    SHOJI, H
    KANGAWA, K
    KITAMURA, K
    ETO, T
    MATSUO, H
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 207 (01) : 25 - 32
  • [49] Induction of tumor necrosis factor α and interleukin-1β in subcutaneously implanted chamber by lipopolysaccharide
    Shapira, L
    Soskolne, A
    Halabi, A
    Barak, V
    Stabholz, A
    JOURNAL OF ENDOTOXIN RESEARCH, 1997, 4 (05): : 325 - 329
  • [50] DENDRITIC CELL LOSS FROM NONLYMPHOID TISSUES AFTER SYSTEMIC ADMINISTRATION OF LIPOPOLYSACCHARIDE, TUMOR-NECROSIS-FACTOR, AND INTERLEUKIN-1
    ROAKE, JA
    RAO, AS
    MORRIS, PJ
    LARSEN, CP
    HANKINS, DF
    AUSTYN, JM
    JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (06): : 2237 - 2247